Schizophrenia
Conditions
Interventions
We perform swallowing tests and record the swallowing latency before and after administration of aripiprazole in schizophrenia patients with symptoms or signs of aspiration.
Sponsors
Institute of Development, Aging and Cancer, Tohoku University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Eligible are schizophrenia patients older than 30 years having symptoms or signs of aspiration.
Exclusion criteria
Exclusion criteria: We exclude patients with delirium and infections.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We perform swallowing tests and measure swallowing latency in selected patients before and after administration of aripiprazole. | — |
Countries
Japan
Contacts
Public ContactTakashi Ohrui
Institute of Development, Aging and Cancer, Tohoku University Division of Geriatric Pharmacotherapy
Outcome results
None listed